Trinity Delta - Futura Medical Profitability in sight as partner preps for US launch
10 April 2024
Trinity Delta Futura Medical Eroxon continues to build, further new launches expected
06 February 2024
Trinity Delta Futura Medical Significant achievements position MED3000 for success
18 September 2023
Trinity Delta Futura Medical First months of Eroxon launch suggest a successful start
01 June 2023
Trinity Delta Futura Medical MED3000 FDA clearance marks a major step in the US
01 June 2023
Trinity Delta Futura Medical MED3000 soft launch in Europe , FDA approval now Q2
01 March 2023
Trinity Delta Futura Medical MED3000 continues to progress towards first sales
01 December 2022
Trinity Delta Futura Medical Interims highlight positive first signs in key markets
13 September 2022
Trinity Delta Futura Medical FM71 achieves all primary and secondary endpoints
31 August 2022
Trinity Delta Futura Medical Major MED3000 deal for Europe with Cooper Health
22 May 2022
Trinity Delta Futura Medical FY21 results reassure on cash runway and hint at EU deal
22 April 2022
Trinity Delta Futura Medical Menarini to commercialise MED3000 in South Korea
23 March 2022
Trinity Delta Futura Medical : A Year of delivery , with key milestones achieved
30 September 2021
Trinity Delta Futura Medical Raising £12m through £10m placing and £2m retail offer
17 May 2021
Trinity Delta Futura Medical MED3000 receives CE Mark as a Class II(b) device
30 April 2021
Trinity Delta Futura Medical MED3000 on course for OTC approval in Europe and US
16 September 2020